| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-Melanocyte-Stimulating Hormone Receptor in Cultured Mast Cells of Mice1 ,2
Department of Pathology, Osaka University Medical School, Suita, Japan
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-melanocyte-stimulating hormone. The
overexpression of the wild-type (+/+) MITF but not
mi-MITF normalized the expression of the MC1R in
mi/mi CMCs, indicating the involvement of
+-MITF in the MC1R gene expression. Next, we analyzed the promoter
region of the MC1R gene by the transient cotransfection assay. The
luciferase construct under the control of the MC1R promoter and the
cDNA-encoding +-MITF or mi-MITF were cotransfected into
NIH/3T3 fibroblasts. The cotransfection of +-MITF but not
mi-MITF increased the luciferase activity. There were
five CANNTG motifs recognized by bHLH-Zip-type transcription factors in
the cloned promoter region. We found +-MITF bound two of five CANNTG
motifs, and both motifs were essential for the transactivation of the
MC1R gene by +-MITF. These results indicated that +-MITF directly
transactivated the MC1R gene through these two
motifs. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-melanocyte-stimulating
hormone (-MSH)4 is
essential for synthesis of melanin in melanocytes (1). In
addition, there have been a number of pieces of evidence showing that
-MSH influences various inflammatory or immunological conditions by
modulating function of lymphocytes (2, 3), neutrophils
(4), or macrophages (5, 6, 7, 8). We recently
reported that murine cultured mast cells (CMCs) expressed a receptor
for -MSH (MC1R) and that -MSH inhibited histamine release from
CMCs and the synthesis of proinflammatory cytokines in stimulated CMCs
(9). The microphthalmia (mi) locus of mice encodes a member of the basic-helix-loop-helix-leucine zipper (bHLH-Zip) protein family of transcription factors (mi-transcription factor, MITF) (10, 11). The MITF encoded by the mutant mi allele (mi-MITF) deletes 1 of 4 consecutive arginines in the basic domain (10, 12, 13). Thus mi-MITF is defective in the DNA binding activity and the nuclear translocation, resulting in defective transactivation of target genes (14, 15). The mutant mice of mi/mi genotype show microphthalmia, deletion of pigment in both hair and eyes, osteopetrosis, and a decrease in the number of mast cells (16, 17, 18, 19, 20). In addition to decreased number of mast cells, the phenotype of mast cells is abnormal in mi/mi mice (20, 21, 22, 23). The expression of the mouse mast cell protease 6 (MMCP-6) (24), c-kit receptor tyrosine kinase (25), p75 nerve growth factor (NGF) receptor (26), MMCP-5 (27), granzyme B (Gr B) (28), tryptophan hydroxylase (TPH) (28), and MMCP-4 genes (29) are reduced in skin mast cells of mi/mi mice. The involvement of normal (+)-MITF (+-MITF) in the transactivation of these genes has been demonstrated in CMCs.
Because MITF regulates the expression of many genes in mast cells, we examined a possibility that MITF regulated MC1R expression using mi/mi CMCs, in which the transactivation by MITF was deficient. The subtracted cDNA library of (+/+ CMCs-mi/mi CMCs) contained the cDNA for MC1R, but the cDNA library obtained from mi/mi CMCs did not. Overexpression of +-MITF normalized the expression of the MC1R gene in mi/mi CMCs. +-MITF bound the neighboring two CANNTG motifs in the cloned promoter region of the MC1R gene and transactivated the MC1R gene through the two motifs. These results suggested +-MITF regulated the MC1R gene expression in mouse mast cells.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The original stock of C57BL/6-mi/+ mice was purchased
from The Jackson Laboratory (Bar Harbor, ME) and maintained in our
laboratory by consecutive backcrosses to our own inbred C57BL/6 colony.
Female and male mi/+ mice were crossed together, and the
resulting mi/mi mice were selected by their white
coat color (16, 17). The original stock of
VGA-9-tg/tg mice, in which the mice
vasopressin-Escherichia coli 
-galactosidase transgene was
integrated at the 5' flanking region of the mi (MITF) gene,
were kindly given by Dr. H. Arnheiter (National Institutes of Health,
Bethesda, MD). The integrated transgene was maintained by repeated
backcrosses to our own inbred C57BL/6 colony. Female and male
tg/+ mice were crossed together, and the resulting
tg/tg mice were selected by their coat color
(10).
Cells
CMCs were established from mi/mi,
tg/tg, and control +/+ mice as described
previously (29), and maintained in -minimal essential
medium (-MEM; ICN Biomedicals, Costa Mesa, CA) supplemented with
10% PWM-stimulated spleen cell-conditioned medium (PWM-SCM) and 10%
FCS (Nippon Biosupp Center, Tokyo, Japan). The helper virus-free
packaging cell line (
2) was maintained in DMEM (ICN Biomedicals)
supplemented with 10% FCS (30). The NIH/3T3 cell line was
generously provided by Dr. S. A. Aaronson (National Cancer
Institute, Bethesda, MD) and maintained in DMEM supplemented with 10%
FCS. The murine mastocytoma cell line, FMA/3, was generously given by
Dr. H. Hasegawa (Nishi-Tokyo University, Yamanashi, Japan) and
maintained in -MEM supplemented with 10% FCS.
MC1R detection in the subtracted cDNA library
The detailed process for the preparation of the subtracted cDNA library was described previously (28). ssDNA was prepared from the plasmid DNA from the +/+ CMCs cDNA library. Biotinylated RNA drivers were prepared from mi/mi CMCs by photobiotin (Vector Lab, Burlingame, CA). ssDNA prepared from the +/+ CMCs cDNA Library was hybridized with biotinylated RNA. After hybridization for 42 h, streptavidin was added into the mixture and extracted with phenol/chloroform/isoamyl alcohol. The aqueous phases were pooled. Streptavidin binding and phenol treatment were repeated once more. After repeating the subtraction process, the recovered ssDNA was converted to dsDNA. To detect MC1R, PCR was employed using +/+, mi/mi CMCs cDNA library, or the subtracted cDNA library (+/+-mi/mi) as a template. PCR was performed in a thermocycler (Astec, Tokyo, Japan) as follows: 94°C, 5 min; followed by 35 amplification cycles (94°C for 30 s; 60°C for 1 min; 72°C for 1 min). The sequence of the primers for MC1R are follows: the upper strand, GTG AGT CTG GTG GAG AAT GTG; and the lower strand, TTT TGT GGA GCT GGG CAA TGC (5). The PCR products were electrophoresed in 1.2% agarose gel containing ethidium bromide.
Semiquantitative RT-PCR
Total RNA was isolated from +/+, mi/mi, or tg/tg CMCs by the guanidine thiocyanate/phenol-chloroform extraction method and was treated with RNase-free DNase (Boehringer Mannheim, Mannheim, Germany) to remove genomic DNA. RNA (5.0, 0.5, and 0.05 µg) was reverse transcribed in 20 µl of the reaction mixture containing 20 U of avian myeloblastosis virus reverse transcriptase (Life Technologies, Gaithersburg, MD) and random hexamer. PCR was performed in the same conditions described above, and the PCR products were electrophoresed in 1.2% agarose gel containing ethidium bromide.
Construction of retrovirus vector and its infection
Bluescript KS(-) plasmid (pBS; Strategene, La Jolla, CA)
containing the whole coding region of +-MITF or mi-MITF
(pBS-+-MITF or pBS-mi-MITF, respectively) had been
constructed in our laboratory (14, 15). A retroviral
vector pM5Gneo (31), a derivative of myeloproliferative
sarcoma virus vector, was a kind gift from Dr. W. Ostertag (Universitat
Hamburg, Hamburg, Germany). The purified
SmaI-HincII fragment from pBS-+-MITF or
pBS-mi-MITF was introduced into the blunted EcoRI
site of pM5Gneo. The resulting plasmids (hereafter called
pM5Gneo-+-MITF or pM5Gneo-mi-MITF, respectively) were
transfected into the packaging cell line (2) (30) using
the calcium phosphate method, and neomycin-resistant 2 cell clones
were selected by culturing in DMEM containing 10% FCS and G418 (0.8
mg/ml, Life Technologies, Grand Island, NY). For the gene transfer,
spleen cells obtained from mi/mi mice were
incubated on irradiated (30 Gy) subconfluent monolayer of
virus-producing 2 cells for 72 h in -MEM supplemented
with 10% PWM-SCM and 10% FCS. Neomycin-resistant CMCs were obtained
by continuing the culture in -MEM supplemented with 10% PWM-SCM,
10% FCS, and G418 (0.8 mg/ml) for 4 wk.
Isolation of the promoter region of the MC1R gene
The isolation of the promoter region of the MC1R gene was performed with the Mouse Promoter Finder Kit (Clontech Laboratories, Palo Alto, CA) according to the manufacturer’s instructions. The isolated promoter region was cloned into pBS and sequenced.
Construction of effector and reporter plasmids
The pEF-BOS expression vector was kindly provided by Dr. S. Nagata (Osaka University Medical School, Suita, Japan). The SmaI-HincII fragment of pBS-+-MITF or pBS-mi-MITF was introduced into the blunted XbaI site of pEF-BOS (BOS-+-MITF or BOS-mi-MITF, respectively). The luciferase gene subcloned into pSP72 (pSPLuc) was generously provided by Dr. K. Nakajima (Osaka University Medical School, Suita, Japan) (32). To construct reporter plasmids, a DNA fragment containing a promoter region and the first exon of the MC1R gene (nt -780 to +44) was cloned into the upstream of luciferase gene in pSPLuc. The deletion of MC1R promoter was produced using PCR and subcloned into pBS. A BamHI-HindIII fragment of the pBS-PCR product was cloned into pSPLuc. The mutation was introduced by PCR with mismatch primers. Deleted or mutated products were verified by sequencing.
Transfection of reporter plasmids and luciferase assay
NIH/3T3 cells (5 x 105) were plated
in a 10-cm plastic dish 1 day before the procedure. Cotransfection with
5 µg of reporter plasmids, 100 ng of effector plasmids, and 5 µg of
an expression vector containing -galactosidase gene was performed by
the calcium phosphate precipitation method. The expression vector
containing the -galactosidase gene was used as an internal control.
Because FMA/3 cells express the MITF gene by themselves
(25), the reporter plasmids (5 µg) and the expression
vector containing -galactosidase gene were added to the cell
suspension. For gene transfer, FMA/3 cells were electroporated by a
single pulse (300 V, 950 µF) from a Gene Pulser II (Bio-Rad
Laboratories, Richmond, CA). NIH/3T3 cells were harvested 48 h
after transfection; FMA/3 cells were harvested 24 h after
transfection. The cells were lysed with 0.1 M potassium phosphate
buffer (pH 7.4) containing 1% Triton X-100. Soluble extracts were then
assayed for luciferase activity with a luminometer LB96P (Berthold,
Wildbad, Germany) and for -galactosidase activity. Luciferase
activity was normalized by -galactosidase activity and total protein
concentration.
EMSA
The production and purification of GST-+-MITF or
GST-mi-MITF fusion protein was described previously
(14). Oligonucleotides were labeled with
[-32P]dCTP by filling 5'-overhangs and used
as probes of EMSA. DNA-binding assays were performed in a 20-µl
reaction mixture containing 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 75 mM
KCl, 1 mM DTT, 4% Ficoll type 400, 50 ng of poly(dI-dC), 25 ng of
labeled DNA probe, and 1.0 µg of GST-+-MITF fusion protein. After
incubation at room temperature for 15 min, the reaction mixture was
subjected to electrophoresis at 14 V/cm on a 5% polyacrylamide gel in
0.25x TBE buffer (1 x TBE in 90 mM Tris-HCl, 64.6 mM boric acid,
and 2.5 M EDTA, pH 8.3). The polyacrylamide gels were dried on Whatman
3 MM chromatography paper (Whatman, Maidstone, U.K.) and subjected to
autoradiography.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We examined whether the subtracted cDNA library
(+/+-mi/mi) contained the cDNA for MC1R. The PCR
products obtained from the subtracted cDNA library
(+/+-mi/mi) and from cDNA library of +/+ CMCs
contained an amplified single band. But no amplified band was observed
in the product from mi/mi cDNA library (Fig. 1
A). The expression of the
MC1R gene in +/+, mi/mi, or
tg/tg CMCs was also examined using
semiquantitative RT-PCR. The expression of the MC1R gene was
undetectable in not only mi/mi but also
tg/tg CMCs. In contrast, +/+ CMCs expressed the
MC1R gene (Fig. 1B). Next, we introduced the cDNA encoding
+-MITF or mi-MITF to mi/mi CMCs. The
magnitude of mRNA expression of +-MITF was comparable to that of
mi-MITF, and the expression level of the introduced +-MITF
or mi-MITF was much greater than that of endogenous
mi-MITF (data not shown). The expression of MC1R mRNA
recovered to the normal level in mi/mi CMCs
overexpressing +-MITF but did not in mi/mi CMCs
overexpressing mi-MITF (Fig. 1C).
|
The normalized expression of the MC1R gene in
mi/mi CMCs overexpressing +-MITF indicated the
involvement of +-MITF in the regulation of MC1R gene expression. To
investigate the regulation mechanism, we cloned 780 bases of the
5'-upstream region of the MC1R gene (Fig. 2). The reporter plasmid that contained
the luciferase gene under the control of the MC1R gene promoter
(starting from nt -780; +1 shows the transcription initiation site)
was constructed. There were five CANNTG motifs, which might be
recognized by bHLH-Zip protein family of transcription factors. Thus we
also constructed the reporter plasmid containing the deleted MC1R
promoter starting from nt -483, -470, -295, -155, -45, or -25.
These reporter plasmids were transfected into the FMA/3 mastocytoma
cells, which constitutively expressed both +-MITF and MC1R mRNAs (data
not shown). When the reporter plasmid containing the MC1R promoter
starting from -780 was transfected, the luciferase activity was low.
On the other hand, when the reporter plasmid containing the MC1R
promoter starting from nt -483 was transfected, the luciferase
activity increased about 60-fold (Fig. 3). The transfection of MC1R promoter
starting from nt -470, -295, -155, or -45 did not show a
significant increase of the luciferase activity. These studies
suggested that the responsible region for the transactivation of the
MC1R gene existed in the promoter starting from nt -483.
|
|
We sought to identify the motif that mediated the transactivation
of the MC1R gene by +-MITF. The reporter plasmid containing MC1R
promoter starting from nt -780, -483, -470, -295, -155, -45, or
-25 was cotransfected with +-MITF into NIH/3T3 fibroblasts, which did
not express endogenous +-MITF gene (26). Slightly
increased luciferase activity was observed in the presence of +-MITF
when the reporter plasmid containing MC1R promoter starting from nt
-780 was transfected. On the other hand, significant luciferase
activity (6.5-fold) was induced in the presence of +-MITF when the
plasmid containing MC1R promoter starting from nt -483 (Fig. 4). Cotransfection of +-MITF did not
induce a significant luciferase activity in the deleted promoter from
nt -470, -295, -155, or -45. In contrast, cotransfection of
mi-MITF did not increase a luciferase activity in any
promoter constructs. These data suggested the importance of the
promoter region from nt -483 to -471 for the transactivation of the
MC1R gene by +-MITF. Because the CACATG motif from nt -477 to -472
exists close to the CATGTG motif from nt -466 to -461, the
possibility that the latter motif also has a role in the
transactivation of the MC1R gene still remained. The participation of
the CATGTG motif in the transactivation could not be excluded using the
deleted promoter constructs. Therefore, we cloned the reporter plasmids
containing the MC1R gene promoter from nt -483 with the mutations in
the CACATG motif and/or the CATGTG motif. The mutation in the CACATG
motif (from nt -477 to -472) completely abolished the luciferase
activity as seen in the assay with the deleted promoter from nt -470
(Fig. 5). The mutation in the CATGTG
motif (from nt -466 to -461) also completely abolished the luciferase
activity.
|
|
, lane
2), and the specificity was demonstrated using the excess of
nonlabeled oligonucleotide (lanes 3 and
4). The binding was inhibited by the competitor containing
either the mutated CACATG motif (CACATG to
CTCAAG) or the mutated CATGTG motif (CATGTG
to CTTGAG) (lanes
5-8). But the magnitude of the inhibition by the
competitor containing the mutated CACATG motif was significantly larger
than that by the competitor containing the mutated CATGTG motif. The
excess of the competitor containing the mutations in both the CACATG
motif and the CATGTG motif did not affect the binding of +-MITF protein
to the probe.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We sequenced the 5' flanking region of the murine MC1R gene to analyze the transactivation mechanism by +-MITF. The transfection of the reporter plasmid starting from nt -483 of the MC1R promoter into FMA/3 cells resulted in the high luciferase activity. The results suggested that the promoter activity existed between nt -483 to -471 of the 5' flanking region of the MC1R gene. But it was uncertain whether +-MITF, but not other transcription factors, transactivated the MC1R gene. Thus, we cotransfected both the reporter plasmid and the expression plasmid containing MITF cDNA to determine the role of +-MITF. When the reporter plasmid was cotransfected into NIH/3T3, cotransfection of +-MITF but not mi-MITF increased the luciferase activity, indicating the direct involvement of +-MITF in the transactivation of the MC1R gene. The luciferase assay with the deleted promoter constructs demonstrated the important role of the CACATG motif (nt -477 to -472) in the transactivation by +-MITF. Because the CATGTG motif (nt -466 to -461) located closely to the CACATG motif (nt -477 to -472), there is a possibility that the CATGTG motif is involved in the transactivation by +-MITF. The participation of the CATGTG motif could not be excluded using the deleted promoter constructs. Thus we examined the transactivation using the promoter constructs with the mutations in the CACATG motif and/or the CATGTG motif. The mutations in either the CACATG motif or the CATGTG motif completely abolished the transactivation by +-MITF. These results indicated the motifs did not work additively, but both motifs were indispensable for the transactivation of the MC1R gene. Because the binding of +-MITF protein to the oligonucleotide containing both the CACATG and the CATGTG motifs was significantly inhibited by the excess of the competitor containing either the mutated CACATG or the mutated CATGTG motif, +-MITF protein appeared to bind both the CACATG and the CATGTG motifs. But the magnitude of the binding of +-MITF protein to the CATGTG motif was different from that to the CACATG motif. This may reflect the difference of the binding affinities of +-MITF to the motifs. However, there could be another explanation that coactivators were required for efficient binding of +-MITF to a particular element of DNA. The neighboring two CANNTG motifs are reminiscent of the promoter of the c-kit (25), MMCP-6 (24), and MMCP-4 genes (29). Although there were two CANNTG motifs separated by only one nucleotide in the promoter region of the c-kit gene, +-MITF bound only the former motif. In the case of the MMCP-4 gene, +-MITF bound only the former motif, and the latter did not affect the transactivation by +-MITF. On the other hand, +-MITF bound both of the two motifs separated by 11 nucleotides in the promoter region of the MMCP-6 gene. Unlike the MC1R gene, both motifs in the promoter region of the MMCP-6 gene appeared to work additively for the transactivation by +-MITF.
Because there are a few but important similarities between mast cells
and melanocytes (34), there is a possibility that MITF
regulates the MC1R expression also in melanocytes. In fact, -MSH has
been known to increase the expression of MITF in melanocytes
(35), and -MSH also increases the expression of MC1R in
melanocytes (36, 37). These findings seem to support the
possibility that MITF regulates the MC1R gene expression in
melanocytes. Because -MSH increases the MITF expression and MITF
induces the MC1R expression, the regulation of the MC1R gene seems to
be a kind of positive feedback by -MSH.
In conclusion, MITF regulates the expression of the MC1R gene in CMCs.
-MSH has been known to modulate inflammatory conditions through the
MC1R on T cells, B cells, macrophages, neutrophils (38),
and mast cells (9). Because MC1R signaling appears to
inhibit proinflammatory effects and MITF transactivates the MC1R gene,
MITF can promote antiinflammatory effects by regulating the expression
of the MC1R gene. This would be the first suggestion of MITF promoting
antiinflammatory effects.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
2 The sequence presented in this article has been submitted to GenBank under accession number AF176016.
3 Address correspondence and reprint requests to Dr. Yukihiko Kitamura, Department of Pathology, Osaka University Medical School, Yamada-oka 2-2, Suita 565-0871, Japan. E-mail address:
4 Abbreviations used in this paper: -MSH, -melanocyte-stimulating hormone; MITF, microphthalmia-associated transcription factor; MC1R, melanocortin receptor type 1; CMC, cultured mast cell; MMCP, mouse mast cell protease; bHLH-Zip, basic-helix-loop-helix-leucine zipper; mi-MITF, MITF encoded by the mutant mi allele; SCM, spleen cell-conditioned medium; pBS, Bluescript KS(-) plasmid.
Received for publication August 23, 1999. Accepted for publication November 2, 1999.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 11:1199.[Medline]
-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17:675.[Medline]
-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. USA 92:8016.-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J. Leukocyte Biol. 59:248.[Abstract]
-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J. Immunol. 158:3378.[Abstract]
-melanocyte stimulating hormone. J. Immunol. 163:3363.-melanocyte stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res. 54:2604.-MSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes. J. Invest. Dermatol. 105:655.[Medline]
-MSH. Immunol. Today 18:140.[Medline]
This article has been cited by other articles:
|
|
 |
|
  I. J. Jackson, P. S. Budd, M. Keighren, and L. McKie Humanized MC1R transgenic mice reveal human specific receptor function Hum. Mol. Genet., October 1, 2007; 16(19): 2341 - 2348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Meadows, S. M. Sharma, G. J. Faulkner, M. C. Ostrowski, D. A. Hume, and A. I. Cassady The Expression of Clcn7 and Ostm1 in Osteoclasts Is Coregulated by Microphthalmia Transcription Factor J. Biol. Chem., January 19, 2007; 282(3): 1891 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev, October 1, 2006; 86(4): 1309 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Chin, L. A. Garraway, and D. E. Fisher Malignant melanoma: genetics and therapeutics in the genomic era. Genes & Dev., August 15, 2006; 20(16): 2149 - 2182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. de la Serna, Y. Ohkawa, C. Higashi, C. Dutta, J. Osias, N. Kommajosyula, T. Tachibana, and A. N. Imbalzano The Microphthalmia-associated Transcription Factor Requires SWI/SNF Enzymes to Activate Melanocyte-specific Genes J. Biol. Chem., July 21, 2006; 281(29): 20233 - 20241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lin, A. J. Gerth, and S. L. Peng Active Inhibition of Plasma Cell Development in Resting B Cells by Microphthalmia-associated Transcription Factor J. Exp. Med., November 8, 2004; (2004) jem.20040612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Catania, S. Gatti, G. Colombo, and J. M. Lipton Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation Pharmacol. Rev., March 1, 2004; 56(1): 1 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Nachman, H. E. Hoekstra, and S. L. D'Agostino The genetic basis of adaptive melanism in pocket mice PNAS, April 29, 2003; 100(9): 5268 - 5273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Takemoto, Y.-J. Yoon, and D. E. Fisher The Identification and Functional Characterization of a Novel Mast Cell Isoform of the Microphthalmia-associated Transcription Factor J. Biol. Chem., August 9, 2002; 277(33): 30244 - 30252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jimenez-Cervantes, M. Martinez-Esparza, C. Perez, N. Daum, F. Solano, and J. C. Garcia-Borron Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor J. Cell Sci., March 8, 2002; 114(12): 2335 - 2344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Morii, K. Oboki, T. R. Kataoka, K. Igarashi, and Y. Kitamura Interaction and Cooperation of mi Transcription Factor (MITF) and Myc-associated Zinc-finger Protein-related Factor (MAZR) for Transcription of Mouse Mast Cell Protease 6 Gene J. Biol. Chem., March 1, 2002; 277(10): 8566 - 8571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Makova, M. Ramsay, T. Jenkins, and W.-H. Li Human DNA Sequence Variation in a 6.6-kb Region Containing the Melanocortin 1 Receptor Promoter Genetics, July 1, 2001; 158(3): 1253 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. H. Kijas, M. Moller, G. Plastow, and L. Andersson A Frameshift Mutation in MC1R and a High Frequency of Somatic Reversions Cause Black Spotting in Pigs Genetics, June 1, 2001; 158(2): 779 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Morii, H. Ogihara, K. Oboki, C. Sawa, T. Sakuma, S. Nomura, J. D. Esko, H. Handa, and Y. Kitamura Inhibitory effect of the mi transcription factor encoded by the mutant mi allele on GA binding protein-mediated transcript expression in mouse mast cells Blood, May 15, 2001; 97(10): 3032 - 3039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Morii, H. Ogihara, D.-K. Kim, A. Ito, K. Oboki, Y.-M. Lee, T. Jippo, S. Nomura, K. Maeyama, M. L. Lamoreux, et al. Importance of leucine zipper domain of mi transcription factor (MITF) for differentiation of mast cells demonstrated using mice/mice mutant mice of which MITF lacks the zipper domain Blood, April 1, 2001; 97(7): 2038 - 2044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Goding Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage Genes & Dev., July 15, 2000; 14(14): 1712 - 1728. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
